About Michael Wallace
Michael Wallace is co-founder and chief technology officer of KOKO Medical, a medical device and women's health company in Malvern, Pennsylvania. He runs the medical device incubator 880 Medical and is a part-time venture partner at ShangBay Medical. He also sits on the boards of Septal Solutions, Venova Medical and Aortic Solutions, Inc., and on the advisory board of Fluid Biomed.
Fluid Biomed's bio says Wallace has co-founded five companies and had four exits. He also co-founded Early Bird Medical. He sold DeVoro Medical, where he was CEO, to Boston Scientific in 2021. He sold TW Medical and 880 Medical to Stryker in 2015 and 2017, and CardioProlific to Philips in 2018. Earlier he spent 10 years at Target Therapeutics/Boston Scientific and 12 years at BARRX Medical, Baxano and Silk Road Medical. He holds bachelor's and master's degrees in mechanical engineering (BSME and MSME) from the University of Delaware and UC Davis.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Michael Wallace in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Wallace works with at each company, as listed on that company's latest Form D.
Michael Wallace in the News
Sources
- SECSeptal Solutions, Inc. Form D, filed Oct 27, 2026
- SECAortic Solutions, Inc. Form D, filed Jun 5, 2026
- SECKoKo Medical, Inc. Form D, filed Feb 13, 2026
- SECVenova Medical Inc Form D, filed Aug 16, 2024
- Other company siteVenova Medical home page (Board of Directors, photo and LinkedIn link in his entry)
- Company siteAbout page on septalsolutionsinc.com (board of directors lists Michael Wallace)
- PressHankin Group, 2024-11-18 (describes KOKO Medical as a medical device and women's health company)